Gene:
CCRN4L
CCR4 carbon catabolite repression 4-like (S. cerevisiae)

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

Overview

Alternate Names:  None
Alternate Symbols:  CCR4; CCR4L; Ccr4c
PharmGKB Accession Id: PA26176

Details

Cytogenetic Location: chr4 : q31.1 - q31.1
GP mRNA Boundary: chr4 : 139936913 - 139967093
GP Gene Boundary: chr4 : 139926913 - 139970093
Strand: plus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

NCBI Gene:
25819
OMIM:
608468
UCSC Genome Browser:
NM_012118
RefSeq RNA:
NM_012118
RefSeq Protein:
NP_036250
RefSeq DNA:
NT_016354
UniProtKB:
Q8WTX0_HUMAN (Q8WTX0)
NOCT_HUMAN (Q9UK39)
Ensembl:
ENSG00000151014
GenAtlas:
CCRN4L
GeneCard:
CCRN4L
MutDB:
CCRN4L
ALFRED:
LO003287U
HuGE:
CCRN4L
Comparative Toxicogenomics Database:
25819
ModBase:
Q9UK39
HumanCyc Gene:
HS07702
HGNC:
14254

Common Searches